Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium

Link T, Backstrom M, Graham R, Essers R, Zörner K, Gätgens J, Burchell J, Taylor-Papadimitriou J, Hansson G, Noll T (2004)
Journal of Biotechnology 110(1): 51-62.

Zeitschriftenaufsatz | Englisch
 
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Link, T; Backstrom, M; Graham, R; Essers, R; Zörner, K; Gätgens, J; Burchell, J; Taylor-Papadimitriou, J; Hansson, G; Noll, ThomasUniBi
Erscheinungsjahr
2004
Zeitschriftentitel
Journal of Biotechnology
Band
110
Ausgabe
1
Seite(n)
51-62
ISSN
0168-1656
Page URI
https://pub.uni-bielefeld.de/record/2395241

Zitieren

Link T, Backstrom M, Graham R, et al. Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology. 2004;110(1):51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., et al. (2004). Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology, 110(1), 51-62. https://doi.org/10.1016/j.jbiotec.2003.12.008
Link, T, Backstrom, M, Graham, R, Essers, R, Zörner, K, Gätgens, J, Burchell, J, Taylor-Papadimitriou, J, Hansson, G, and Noll, Thomas. 2004. “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”. Journal of Biotechnology 110 (1): 51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., Taylor-Papadimitriou, J., Hansson, G., and Noll, T. (2004). Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology 110, 51-62.
Link, T., et al., 2004. Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology, 110(1), p 51-62.
T. Link, et al., “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”, Journal of Biotechnology, vol. 110, 2004, pp. 51-62.
Link, T., Backstrom, M., Graham, R., Essers, R., Zörner, K., Gätgens, J., Burchell, J., Taylor-Papadimitriou, J., Hansson, G., Noll, T.: Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium. Journal of Biotechnology. 110, 51-62 (2004).
Link, T, Backstrom, M, Graham, R, Essers, R, Zörner, K, Gätgens, J, Burchell, J, Taylor-Papadimitriou, J, Hansson, G, and Noll, Thomas. “Bioprocess development for a recombinant Mucin-1 fusion protein expressed by CHO cells in protein-free medium”. Journal of Biotechnology 110.1 (2004): 51-62.

23 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.
Hadjialirezaei S, Picco G, Beatson R, Burchell J, Stokke BT, Sletmoen M., PLoS One 12(4), 2017
PMID: 28414807
2D-DIGE screening of high-productive CHO cells under glucose limitation--basic changes in the proteome equipment and hints for epigenetic effects.
Wingens M, Gätgens J, Schmidt A, Albaum SP, Büntemeyer H, Noll T, Hoffrogge R., J Biotechnol 201(), 2015
PMID: 25612871
The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.
Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM., PLoS One 10(5), 2015
PMID: 25951175
Modeling of cell culture damage and recovery leads to increased antibody and biomass productivity in CHO cell cultures.
Naderi S, Nikdel A, Meshram M, McConkey B, Ingalls B, Budman H, Scharer J., Biotechnol J 9(9), 2014
PMID: 24852214
Breaking limitations of complex culture media: functional non-viral miRNA delivery into pharmaceutical production cell lines.
Fischer S, Wagner A, Kos A, Aschrafi A, Handrick R, Hannemann J, Otte K., J Biotechnol 168(4), 2013
PMID: 23994267
A miniaturized bioreactor system for the evaluation of cell interaction with designed substrates in perfusion culture.
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., J Tissue Eng Regen Med 6 Suppl 3(), 2012
PMID: 22170765
Laboratory production of human prolactin from CHO cells adapted to serum-free suspension culture.
Arthuso FS, Bartolini P, Soares CR., Appl Biochem Biotechnol 167(8), 2012
PMID: 22692846
LC-MS-based metabolic characterization of high monoclonal antibody-producing Chinese hamster ovary cells.
Chong WP, Thng SH, Hiu AP, Lee DY, Chan EC, Ho YS., Biotechnol Bioeng 109(12), 2012
PMID: 22711553
The interactions of astrocytes and fibroblasts with defined pore structures in static and perfusion cultures.
Sun T, Donoghue PS, Higginson JR, Gadegaard N, Barnett SC, Riehle MO., Biomaterials 32(8), 2011
PMID: 21163522
Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology.
Thomsson E, Persson L, Grahn A, Snäll J, Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M, Bergström T., J Virol Methods 175(1), 2011
PMID: 21540058
Overcoming challenges in WAVE Bioreactors without feedback controls for pH and dissolved oxygen.
Yuk IH, Baskar D, Duffy PH, Hsiung J, Leung S, Lin AA., Biotechnol Prog 27(5), 2011
PMID: 21987370
Studies on substrate utilisation in L-valine-producing Corynebacterium glutamicum strains deficient in pyruvate dehydrogenase complex.
Bartek T, Rudolf C, Kerssen U, Klein B, Blombach B, Lang S, Eikmanns BJ, Oldiges M., Bioprocess Biosyst Eng 33(7), 2010
PMID: 20204663
Expression of aberrantly glycosylated tumor mucin-1 on human DC after transduction with a fiber-modified adenoviral vector.
van Leeuwen EB, Cloosen S, Senden-Gijsbers BL, Agervig Tarp M, Mandel U, Clausen H, Havenga MJ, Duffour MT, García-Vallejo JJ, Germeraad WT, Bos GM., Cytotherapy 8(1), 2006
PMID: 16627342
Process parameter shifting: Part I. Effect of DOT, pH, and temperature on the performance of Epo-Fc expressing CHO cells cultivated in controlled batch bioreactors.
Trummer E, Fauland K, Seidinger S, Schriebl K, Lattenmayer C, Kunert R, Vorauer-Uhl K, Weik R, Borth N, Katinger H, Müller D., Biotechnol Bioeng 94(6), 2006
PMID: 16736530
Immune response to Thomsen-Friedenreich disaccharide and glycan engineering.
Irazoqui FJ, Sendra VG, Lardone RD, Nores GA., Immunol Cell Biol 83(4), 2005
PMID: 16033536
MUC1 as a target antigen for cancer immunotherapy.
Acres B, Limacher JM., Expert Rev Vaccines 4(4), 2005
PMID: 16117706
Development of a closed bioreactor system for culture of tissue-engineered skin at an air-liquid interface.
Sun T, Norton D, Haycock JW, Ryan AJ, MacNeil S., Tissue Eng 11(11-12), 2005
PMID: 16411828

References

Daten bereitgestellt von Europe PubMed Central.

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®
Quellen

PMID: 15099905
PubMed | Europe PMC

Suchen in

Google Scholar